Company Filing History:
Years Active: 2019
Title: Do-Ran Kim: Innovator in A3 Adenosine Receptor Research
Introduction
Do-Ran Kim is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of medical research, particularly in the development of compounds that target the A3 adenosine receptor. His work aims to address various diseases, including glaucoma and related ocular disorders.
Latest Patents
Do-Ran Kim holds a patent for "Compounds antagonizing A3 adenosine receptor, method for preparing them, and medical-use thereof." This patent provides valuable compounds that can be utilized in the amelioration, prevention, or treatment of A3 adenosine receptor-mediated diseases. The compounds are designed to improve the management of conditions such as glaucoma, offering new hope for patients suffering from these disorders.
Career Highlights
Throughout his career, Do-Ran Kim has been associated with Handok Inc., a leading pharmaceutical company in South Korea. His innovative research has positioned him as a key figure in the development of new therapeutic strategies targeting the A3 adenosine receptor.
Collaborations
Do-Ran Kim has collaborated with notable colleagues, including Jin-Hwa Lee and Seung-Yong Kim. These partnerships have fostered a collaborative environment that enhances the research and development of new medical solutions.
Conclusion
Do-Ran Kim's contributions to the field of medical research, particularly through his patent on A3 adenosine receptor antagonists, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of glaucoma and related conditions.